Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fresenius Medical Care AGFMS -1.14%73 Days Sales Outstanding is 65.19 as of Jun. 2026, which is 6% below its 10-year median of 69.41. GuruFocus rates FMS with a GF Score™ of 73/100 and a GF Value™ of $23.96 (Fairly Valued). The stock has 3 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks worse than 66.06% on this metric.
The historical rank and industry rank for Fresenius Medical Care AG's Days Sales Outstanding or its related term are showing as below:
FMS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 60.97 Med: 69.41 Max: 81.55
Current: 62.12
During the past 13 years, Fresenius Medical Care AG's highest Days Sales Outstanding was 81.55. The lowest was 60.97. And the median was 69.41.
FMS's Days Sales Outstanding is ranked worse than 66.06% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 45.88
vs FMS: 62.12
Fresenius Medical Care AG's Days Sales Outstanding
increased
from Jun. 2025 (62.24) to Jun. 2026 (65.19).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG Days Sales Outstanding Chart
FMS vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's Days Sales Outstanding falls into.
Fresenius Medical Care AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (FMS) has a Days Sales Outstanding of 65.19 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Fresenius Medical Care AG and its competitors. This is near median its historical median of 69.41. Over the past decade, Fresenius Medical Care AG's Days Sales Outstanding has ranged from 60.97 to 81.55. According to the industry distribution chart, Fresenius Medical Care AG ranks #434 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 66.1%.
Is Fresenius Medical Care AG's Days Sales Outstanding too high?
Fresenius Medical Care AG's current Days Sales Outstanding of 65.19 is near median its 10-year median of 69.41. Over the past 10 years, this metric has ranged from a low of 60.97 to a high of 81.55. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.88. Fresenius Medical Care AG's value of 65.19 is 42.1% above this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #434 out of 657 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius Medical Care AG has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #434 out of 657 companies for Days Sales Outstanding. This places Fresenius Medical Care AG in the lower half of its industry. The industry median Days Sales Outstanding is 45.88. Fresenius Medical Care AG's value of 65.19 is 42.1% above this benchmark. Historically, Fresenius Medical Care AG's own Days Sales Outstanding has ranged from 60.97 to 81.55 over the past decade. While the company's 10-year median is 69.41 vs. the industry median of 45.88, Fresenius Medical Care AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.88, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Days Sales Outstanding of 65.19 is 42.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Days Sales Outstanding is 65.19, which is near median its own 10-year median of 69.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $23.96, compared to a current price of $23.50 — trading 1.9% below its estimated fair value. The current Days Sales Outstanding is 65.19, which is near median its 10-year median of 69.41 and 42.1% above the Healthcare Providers & Services industry median of 45.88. Fresenius Medical Care AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Days Sales Outstanding is 65.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMS) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of $23.50 is trading 1.9% below its estimated GF Value™ of $23.96.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMS:
Days Sales Outstanding: 65.19 (near median its 10-year median of 69.41)
GF Value™: $23.96 vs. price of $23.50 (1.9% below fair value)
Industry Position: 42.1% above the Healthcare Providers & Services median (#434 of 657)
No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
73GF Score
Get the complete analysis for FMS
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMS has been successfully added to your 
